(Q53406185)

English

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

Helicobacter pylori

0 references

13

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

author name string

Y S Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

S J Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

J H Yoon

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

K T Suk

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

J B Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

D J Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

D Y Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

H J Min

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

S H Park

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

W G Shin

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

K H Kim

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

H Y Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

language of work or name

0 references

publication date

19 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

34

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

1098-1105

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Two new treatment regimens for Helicobacter pylori eradication: a randomised study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

High eradication rates of Helicobacter pylori with a new sequential treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Treatment after failure: the problem of "non-responders".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Helicobacter pylori detection and antimicrobial susceptibility testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04843.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04843.X

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/21923713

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53406185&oldid=963925970"